References
- Moehler TM, Ho AD, Goldschmidt H, Barlogie B. Angiogenesis in hematologic malignancies [Review]. Crit Rev Oncol Hematol 2003;45:227–244.
- Lenfant M, Wdzieczak-Bakala J, Guittet E, Prome JC, Sotty D, Frindel E. Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc Natl Acad Sci USA 1989;86:779–782.
- Liu JM, Lawrence F, Kovacevic M, et al The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo. Blood 2003;101:3014–3020.
- Wang D, Carretero OA, Yang XY, et al N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivo. Am J Physiol Heart Circ Physiol 2004;287:H2099–H2105.
- Liu JM, Bignon J, Ilic V, et al Evidence for an association of high levels of endogenous AcSDKP, a potent mediator of angiogenesis, with acute myeloid leukemia development. Leuk Lymphoma 2006;47:1915–1920.
- Pradelles Ph, Frobert Y, Creminon C, Liozon E, Massé A, Frindel E. Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analyzed by enzyme immunoassay. Biochem Biophys Res Commun 1990;170:986–993.